Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DPII: Discovery Partners Int'l -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (57)	4/12/2006 6:46:46 PM
From: Mike McFarland	Read Replies (2) \| Respond to of 111

Just starting to skim through the reverse merger filing: This list of Infinity investors is interesting: GROUP 1 SERIES B PREFERRED HOLDERS Prospect Venture Partners Prospect Venture Partners II, L.P. Venrock Associates Venrock Associates III, L.P. Venrock Entrepreneurs Fund III, L.P. GROUP 2 SERIES B PREFERRED HOLDERS Advent Private Equity Fund III ‘A’ Advent Private Equity Fund III ‘B’ Advent Private Equity Fund III ‘C’ Advent Private Equity Fund III ‘D’ Advent Private Equity Fund III ‘A’ Advent Private Equity Fund III GmbH Co. KG Advent Private Equity Fund III Affiliates Advent Management III Limited Partnership Boston University Alexandria Equities, LLC G&H Partners HBM Bioventures (Cayman) Ltd. H&D Investments 2001 Lotus Biosciences Investment Holdings Limited Novartis Bioventures Ltd. POSCO BioVentures I, L.P. Tallwood I, L.P. Vulcan Ventures Inc. Wellcome Trust Limited, as Trustee of the Wellcome Trust Steven H. Holtzman Franklin Moss Stelios Papdopoulos Kimberly Rummelsburg Needless to say, holders of common are way down the list, but I guess the bottom line is we will own 31% more or less, so that is fine. Also, I see that we need to vote for a couple more directors: "In the event that this increase is not approved, Rick Klausner, Eric Lander, Frank Moss and Phil Needleman will step down. Nevertheless, we expect these directors to remain active in the combined company with Rick Klausner, Eric Lander and Phil Needleman serving on its Scientific Advisory Board. " Klausner would be a very good director to have stay! So be sure to vote for the increase in number of directors.